-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Talis Biomedical Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
- Talis Biomedical Corp Operating Income (Loss) for the quarter ending June 30, 2024 was -$9.58M, a 41.6% increase year-over-year.
- Talis Biomedical Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was -$55.1M, a 38.9% increase year-over-year.
- Talis Biomedical Corp annual Operating Income (Loss) for 2023 was -$66.8M, a 42% increase from 2022.
- Talis Biomedical Corp annual Operating Income (Loss) for 2022 was -$115M, a 40% increase from 2021.
- Talis Biomedical Corp annual Operating Income (Loss) for 2021 was -$192M, a 110% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)